See the DrugPatentWatch profile for lipitor

Lipitor, a medication commonly prescribed to manage high cholesterol levels, works by inhibiting a specific enzyme in the liver, not by directly affecting protein synthesis [1]. This enzyme, called HMG-CoA reductase, plays a crucial role in the production of cholesterol within the body [1].

By inhibiting HMG-CoA reductase, Lipitor reduces the liver's ability to produce cholesterol, which in turn stimulates the liver to increase its uptake of low-density lipoprotein (LDL), or "bad" cholesterol, from the bloodstream [1]. This process results in lowered LDL cholesterol levels in the blood, thereby reducing the risk of heart disease [1].

However, Lipitor does not have a direct impact on protein synthesis [1]. While proteins are essential for many bodily functions, including the production of enzymes and structural components, Lipitor's primary mechanism of action is to inhibit cholesterol production [1].

In conclusion, Lipitor influences cholesterol levels by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol production, rather than by affecting protein synthesis.

Sources:
[1] DrugPatentWatch.com. (n.d.). Lipitor (Atorvastatin) - DrugPatentWatch. Retrieved from https://www.drugpatentwatch.com/drugs/lipitor